Amanda J. Craig

2.7k total citations · 1 hit paper
31 papers, 1.4k citations indexed

About

Amanda J. Craig is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Amanda J. Craig has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cancer Research, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Amanda J. Craig's work include Cancer Genomics and Diagnostics (17 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Amanda J. Craig is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Amanda J. Craig collaborates with scholars based in United States, Germany and Spain. Amanda J. Craig's co-authors include Augusto Villanueva, Johann von Felden, Teresa García‐Lezana, Samantha Sarcognato, Doris Germain, Myron Schwartz, Xin Wei Wang, Timothy C. Kenny, Ismaïl Labgaa and Delia D’Avola and has published in prestigious journals such as Nature Genetics, Hepatology and Oncogene.

In The Last Decade

Amanda J. Craig

29 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumour evolution in hepatocellular carcinoma

2019 584 citations Amanda J. Craig, Johann von Felden et al. Nature Reviews Gastroenterology & Hepatology profile →

Peers

Countries citing papers authored by Amanda J. Craig

Since Specialization

Citations

This map shows the geographic impact of Amanda J. Craig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda J. Craig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda J. Craig more than expected).

Fields of papers citing papers by Amanda J. Craig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda J. Craig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda J. Craig. The network helps show where Amanda J. Craig may publish in the future.

Co-authorship network of co-authors of Amanda J. Craig

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda J. Craig. A scholar is included among the top collaborators of Amanda J. Craig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda J. Craig. Amanda J. Craig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism 2024 ·Carcinogenesis ·Yuuki Ohara, Amanda J. Craig, Huaitian Liu, (unknown), (unknown), Tiffany H. Dorsey, Helen Cawley, Azadeh Azizian, Jochen Gaedcke, Michael Ghadimi, Nader Hanna, Stefan Ambs, S. Perwez Hussain	4
2	ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer 2024 ·International Journal of Cancer ·Yuuki Ohara, Huaitian Liu, Amanda J. Craig, Shouhui Yang, (unknown), Tiffany H. Dorsey, Helen Cawley, Azadeh Azizian, Jochen Gaedcke, Michael Ghadimi, Nader Hanna, Stefan Ambs, S. Perwez Hussain	4
3	Lineage and ecology define liver tumor evolution in response to treatment 2024 ·Cell Reports Medicine ·(unknown), Limin Wang, Marshonna Forgues, Shay Behrens, Amanda J. Craig, Meng Liu, Bao Tran, Michael C. Kelly, Anuradha Budhu, Cecilia Monge, Changqing Xie, Jonathan M. Hernandez, Tim F. Greten, Xin Wei Wang, (unknown)	3
4	ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer 2024 ·Carcinogenesis ·(unknown), Yuuki Ohara, Amanda J. Craig, (unknown), (unknown), Tiffany H. Dorsey, (unknown), Gatikrushna Panigrahi, Helen Cawley, Azadeh Azizian, Jochen Gaedcke, Michael Ghadimi, Nader Hanna, S. Perwez Hussain	5
5	MYC determines lineage commitment in KRAS-driven primary liver cancer development 2023 ·Journal of Hepatology ·Luana D’Artista, (unknown), Iros Barozzi, Amanda J. Craig, Marco Seehawer, (unknown), Martina Minnich, Tae-Won Kang, (unknown), (unknown), Sabrina Klotz, Florian Heinzmann, Jule Harbig, Bence Sipos, Thomas Longerich, Martin Eilers, Daniel Dauch, Johannes Zuber, Xin Wei Wang, Lars Zender	18
6	Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD 2022 ·Journal of Hepatology ·Simon Wabitsch, Justin McCallen, Olena Kamenyeva, Benjamin Ruf, John C. McVey, Juraj Kabát, Juliane S. Walz, Yaron Rotman, Kylynda C. Bauer, Amanda J. Craig, Marie Pouzolles, (unknown), (unknown), Benjamin L. Green, (unknown), Laurence P. Diggs, Bernd Heinrich, Xin Wei Wang, Chi Ma, Tim F. Greten	98
7	Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma 2022 ·Frontiers in Immunology ·Bernd Heinrich, Benjamin Ruf, Varun Subramanyam, Yuta Myojin, Chunwei W. Lai, Amanda J. Craig, Jianyang Fu, Changqing Xie, Alexander Kroemer, Tim F. Greten, Firouzeh Korangy	8
8	Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma 2021 ·PLoS Genetics ·Amanda J. Craig, Teresa García‐Lezana, Marina Ruiz de Galarreta, Carlos Villacorta-Martín, Edgar Gonzalez‐Kozlova, Sebastião N. Martins-Filho, Johann von Felden, Mehmet Eren Ahsen, Erin Bresnahan, Gabriela Hernandez‐Meza, Ismaïl Labgaa, Delia D’Avola, Myron Schwartz, Josep M. Llovet, Daniela Sia, Swan N. Thung, Bojan Losic, Amaia Lujambio, Augusto Villanueva	16
9	Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis 2021 ·JHEP Reports ·Dipankar Bhattacharya, (unknown), José M. Mato, Amanda J. Craig, David Fernández‐Ramos, Fernando Lopitz‐Otsoa, (unknown), Liat Hayardeny, Vasuretha Chandar, Robert E. Schwartz, Augusto Villanueva, Scott L. Friedman	60
10	Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma 2020 ·Oncogene ·Johann von Felden, Amanda J. Craig, Teresa García‐Lezana, Ismaïl Labgaa, Philipp K. Haber, Delia D’Avola, Amon Asgharpour, Douglas T. Dieterich, Antoinette Bonaccorso, Miguel Torres‐Martín, Daniela Sia, Max W. Sung, Parissa Tabrizian, Myron Schwartz, Josep M. Llovet, Augusto Villanueva	99
11	Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis 2020 ·Journal of Hepatology ·S. Heinrich, Amanda J. Craig, Lichun Ma, Bernd Heinrich, Tim F. Greten, Xin Wei Wang	64
12	Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology 2019 ·Molecular Cancer Therapeutics ·Jia Xin Yu, Amanda J. Craig, Mary E. Duffy, Carlos Villacorta-Martín, Verónica Miguela, Marina Ruiz de Galarreta, (unknown), (unknown), Andres Y. Maldonado, Alexander Rialdi, Ernesto Guccione, Amaia Lujambio, Augusto Villanueva, Arvin C. Dar	17
13	Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2 2019 ·Breast Cancer Research ·(unknown), Amanda J. Craig, Augusto Villanueva, Doris Germain	21
14	Mitohormesis Primes Tumor Invasion and Metastasis 2019 ·Cell Reports ·Timothy C. Kenny, Amanda J. Craig, Augusto Villanueva, Doris Germain	77
15	Tumour evolution in hepatocellular carcinoma breakdown → 2019 ·Nature Reviews Gastroenterology & Hepatology ·Amanda J. Craig, Johann von Felden, Teresa García‐Lezana, Samantha Sarcognato, Augusto Villanueva	584
16	High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma 2018 ·Scientific Reports ·Delia D’Avola, Carlos Villacorta-Martín, Sebastião N. Martins-Filho, Amanda J. Craig, Ismaïl Labgaa, Johann von Felden, (unknown), Antoinette Bonaccorso, Parissa Tabrizian, Boris Hartmann, Robert Sebra, Myron Schwartz, Augusto Villanueva	62
17	A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma 2018 ·Oncogene ·Ismaïl Labgaa, Carlos Villacorta-Martín, Delia D’Avola, Amanda J. Craig, Johann von Felden, Sebastião N. Martins-Filho, Daniela Sia, Ashley Stueck, Stephen C. Ward, Maria Isabel Fiel, Milind Mahajan, Parissa Tabrizian, Swan N. Thung, Celina Ang, Scott L. Friedman, Josep M. Llovet, Myron Schwartz, Augusto Villanueva	89
18	Divergent evolutionary trajectories in transplanted tumor models 2017 ·Nature Genetics ·Carlos Villacorta-Martín, Amanda J. Craig, Augusto Villanueva	11
19	Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma 2016 ·Cancer Discovery ·Tomoyo Okada, Ann Y. Lee, Li‐Xuan Qin, Narasimhan P. Agaram, Takahiro Mimae, (unknown), Rachael O’Connor, Miguel A. López-Lago, Amanda J. Craig, Martin L. Miller, Phaedra Agius, Evan Molinelli, Nicholas D. Socci, Aimeé M. Crago, Fumi Shima, Chris Sander, Samuel Singer	68
20	Liver capsule: Molecular‐based signatures in hepatocellular carcinoma 2016 ·Hepatology ·Amanda J. Craig, Augusto Villanueva	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact